InvestorsHub Logo
Followers 10
Posts 4220
Boards Moderated 0
Alias Born 07/10/2003

Re: bag8ger post# 22887

Tuesday, 03/22/2005 9:53:30 AM

Tuesday, March 22, 2005 9:53:30 AM

Post# of 82595
bag8ger,

You're going to have to do better than that.

I've been wrong many times. Both here and on the other boards. I have 'fessed' up to numerous mistakes and I will in the future. Being wrong on occasion is the price you pay for thinking for yourself. (You should try it.)

If you need me to get specific about this incident, I was wrong when I suggested that evidence existed that pointed to the completion of the Biofrontera deal. I based that assumption on the fact that Biofrontera altered their web site to include DNAP's participation in their Board of Directors. This occured closer to the end of the transaction period than the beginning. (contrary to your claim).

On to the next subject. You still are distorting my words, even after being corrected. What is your motive for such behavior? Are YOU uncomfortable with being wrong? It is interesting that on the many occasions that you have put your foot in it, you have never admitted your mistakes. Do we have a little Pot and Kettle interaction going on here?

For clarity I will reiterate.

Common sense suggests that the 'story' put forward by DNAP/Biofrontera/Dutchess in regards to the purchase of Biofrontera by DNAP, using funds contributed by Dutchess, in exchange for shares of DNAP, is patently ridiculous.

On the other hand the possibility that 'something' is cooking regarding those three participants has a significant probability, and has seemed obvious from the beginning. Gabriel's insider status at Biofrontera, The carefully worded statements about majority ownership that avoided any reference to 'control', the discrepency of majority ownership vs. a minority position on the BOD, the 'loan', the farcicial episode of Frudakis being 'amazed' by Biofrontera's pipeline as he did his DD AFTER the deal had been announced, the unexplained addition to DNAP's BOD, the negotiation by Biofrontera to sell off some of it's assets while still apparently waiting for the DNAP purchase to close, all infer 'something' is going on.

However, due to the questionable strategy being employed by the parties involved and the misdirection and stonewalling in regards to the public, it is doubtful that 'something' will be welcomed by the investors.

regards,
frog